Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 30 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 10813934

    Sirtuin modulators as inhibitors of cytomegalovirus

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  2. US 10813929

    Treating cancer with ATR inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  3. US 10815271

    Structure-based peptide inhibitors of alpha-synuclein aggregation

    The Regents of the University of California · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  4. US 10815239

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  5. US 10806794

    Protease inhibitors having enhanced features

    Nektar Therapeutics · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  6. US 10808010

    Peptide inhibitors of phosphoglycerate mutase and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  7. US 10806730

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  8. US 10800769

    Heterocyclic inhibitors of ATR kinase

    The Board of Regents of the University of Texas System · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  9. US 10800782

    Inhibitors of cellular metabolic processes

    Agios Pharmaceuticals, Inc. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  10. US 10800781

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  11. US 10800774

    Heterocyclic inhibitors of ATR kinase

    The Board of Regents of the University of Texas System · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  12. US 10792282

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  13. US 10793563

    GCN2 inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  14. US 10786512

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  15. US 10786495

    Vesicular monoamine transporter 2 inhibitors for treating stuttering

    The Regents of the University of California · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  16. US 10787490

    Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

    Protagonist Therapeutics, Inc. · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  17. US 10787452

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  18. US 10781208

    5,6-dihydro-11H-indolo[2,3-B]quinolin-11-ones as alk inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted
  19. US 10781181

    N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors

    KalVista Pharmaceuticals Limited · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted
  20. US 10781183

    Small molecule inducers of reactive oxygen species and inhibitors of mitochondrial activity

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted
  21. US 10781218

    Substituted inhibitors of menin-MLL and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted
  22. US 10772861

    Administration of serine protease inhibitors to the stomach

    The Regents of the University of California · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  23. US 10774092

    ULK1 inhibitors and methods using same

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  24. US 10774056

    Substituted piperazines as selective HDAC1,2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted